Pharmaceutiques (France's leading pharma industry magazine) brings its expertise to the biotech sector offering market insight from insiders in the industry with weekly delivery of BioPharmaceutiques, now available in English as well as French. High quality content is delivered to your e-mail inbox 24/7 web-based access to the latest biotech information, comprehensive summary tables and all back issues. BioPharmaceutiques interprets the sector's news from both a pharma perspective and a resolutely European angle. In short, BioPharmaceutiques provides sector stakeholders with a rapidly assimilated synopsis of who is doing what and with whom.
High-quality content:
European biotech news at a glance.
BioPharmaceutiques focuses on the latest IPOs, M&A activity, investment rounds, clinical trial launches, industry appointments and news on European directives and regulations. Your time is precious, so the BioPharmaceutiques e-newsletter gives you immediate access to a list of headlines with hyperlinks to the full article.
Drilling down:
Using interactive summary tables
Along with weekly updates from the latest editions of the magazine, the dedicated BioPharmaceutiques website gives subscribers 24/7 access to regularly updated summary tables, with interactive molecule-, company- and disease-specific overviews of the latest corporate alliances, clinical trial launches, investments and IPOs.
